{"id":170,"date":"2018-08-28T12:51:30","date_gmt":"2018-08-28T12:51:30","guid":{"rendered":"https:\/\/numbers.otc.duke.edu\/?page_id=170"},"modified":"2023-08-02T13:43:21","modified_gmt":"2023-08-02T13:43:21","slug":"home","status":"publish","type":"page","link":"https:\/\/numbers.otc.duke.edu\/2018-report\/","title":{"rendered":"Home"},"content":{"rendered":"

[vc_row css=”.vc_custom_1535522109481{background-color: #383838 !important;}” el_class=”main-heading”][vc_column css=”.vc_custom_1535525509169{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_column_text]<\/p>\n

2018 ANNUAL REPORT<\/strong><\/h1>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row equal_height=”yes” el_class=”sections” css=”.vc_custom_1690983430632{margin-bottom: 50px !important;}”][vc_column width=”2\/3″ css=”.vc_custom_1535531141367{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_row_inner el_class=”content-overlay-box blue-overlay” css=”.vc_custom_1536327338618{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/09\/scientist-working-PDUEQ7K.jpg?id=607) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_inner][vc_single_image image=”118″ css_animation=”none” el_class=”top-center”][vc_column_text css_animation=”none”]<\/p>\n

$34 Million in Series D Financing Awarded to PhaseBio<\/h2>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp”]<\/p>\n

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, with an initial focus on cardiopulmonary disorders<\/p>\n

[\/vc_column_text][vc_btn title=”Read More” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F09%2F07%2Fphasebio-34m-grant%2F|title:%2434%20Million%20in%20Series%20D%20Financing%20Awarded%20to%20PhaseBio||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1537299920428{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 25px !important;}” el_class=”simple-content-box green-box”][vc_row_inner el_class=”simple-content-box” css=”.vc_custom_1535531544489{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-color: #a1b70d !important;}”][vc_column_inner][vc_single_image image=”64″ el_class=”right-center”][vc_column_text el_class=”heading1″]<\/p>\n

329<\/h2>\n

INVENTIONS DISCLOSED<\/h4>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp” el_class=”heading”]<\/p>\n

An inventor’s first step in the commercialization process<\/p>\n

[\/vc_column_text][vc_btn title=”See More Numbers” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2Fby-the-numbers%2F|title:By%20the%20Numbers||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row el_class=”second-section” css=”.vc_custom_1690983529577{margin-bottom: 50px !important;}”][vc_column el_class=”content-overlay-box sky-blue-overlay teal-box-transparent” css=”.vc_custom_1537299930002{background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/woman-with-brain-tumor-PH7VVTH-e1536324652641.jpg?id=302) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_single_image image=”45″ el_class=”left-center”][vc_column_text]<\/p>\n

NEW START-UP: Cereius, Inc.<\/h2>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp”]<\/p>\n

A biotechnology company developing novel approaches to treat solid tumor brain metastases, Cereius\u2019 intellectual property includes next-generation radiolabeling chemistries developed by Dr. Michael Zalutsky,\u00a0Professor of Radiology, Radiation Oncology and Biomedical Engineering<\/p>\n

[\/vc_column_text][vc_btn title=”Read More About Cereius” align=”center” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F08%2F28%2Fcereius%2F|title:Metastasizing%20brain%20tumor%20start-up%20Cereius%20lands%20%246M%2B||”][\/vc_column][\/vc_row][vc_row equal_height=”yes” el_class=”sections column-3″ css=”.vc_custom_1690983459328{margin-bottom: 50px !important;}”][vc_column width=”1\/3″ css=”.vc_custom_1535534529120{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_row_inner el_class=”content-overlay-box blue-overlay small-text” css=”.vc_custom_1536327911477{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/RobHallford_KevinBowles-e1535633051828.jpg?id=518) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_inner][vc_single_image image=”118″ el_class=”top-center”][vc_column_text]<\/p>\n

Successful 1st Year for New Ventures\u2019 MIR Program<\/h2>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp”]<\/p>\n

OLV\u2019s MIR program didn\u2019t reinvent the start-up wheel \u2014 rather, just enabled it to turn faster and more efficiently.<\/p>\n

[\/vc_column_text][vc_btn title=”Read More” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F08%2F27%2Fmirs-1st-year%2F|title:Successful%201st%20Year%20for%20New%20Ventures%E2%80%99%20MIR%20Program||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1537299938336{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 25px !important;}” el_class=”green-box”][vc_row_inner css=”.vc_custom_1535535282158{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-color: #a1b70d !important;}” el_class=”simple-content-box”][vc_column_inner][vc_single_image image=”64″ el_class=”right-center”][vc_column_text el_class=”heading2″]<\/p>\n

16<\/h2>\n

NEW START-UPS CREATED<\/h4>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp” el_class=”heading2″]<\/p>\n

This year we’ve helped grow and develop ventures ranging from gene therapy to machine learning<\/p>\n

[\/vc_column_text][vc_btn title=”See all our start-ups” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2Fstart-ups%2F|title:Start-Ups||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1535535006456{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 25px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_row_inner el_class=”content-overlay-box blue-overlay small-text” css=”.vc_custom_1536327833935{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/Element-Genomics-.jpg?id=416) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_inner][vc_single_image image=”118″ el_class=”top-center”][vc_column_text]<\/p>\n

Element Genomics Acquired by UCB<\/h2>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp”]<\/p>\n

Novel epigenomic editing techniques to improve understanding of genome structure and function to identify potential new drug targets<\/p>\n

[\/vc_column_text][vc_btn title=”Read More” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F08%2F28%2Felement-genomics-acquired-by-ucb%2F|title:Element%20Genomics%20Acquired%20by%20UCB||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1690983506993{margin-bottom: 50px !important;background: #141f4a url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/anastasia-img-bg.jpg?id=229) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”content-overlay-box blue-overlay-full”][vc_column][vc_column_text css_animation=”fadeInUp”]<\/p>\n

2nd Annual<\/em>
\nINVENTED AT DUKE\u00a0
\nNov 8th, 4-7pm<\/em><\/h2>\n

You\u2019re invited to come and connect with Duke researchers, entrepreneurs, CEOs, and investors. Meet some of our featured innovators as they show off their inventions and novel ideas. This event will honor Duke faculty, staff, and students whose research has the potential to improve and save lives.<\/p>\n

[\/vc_column_text][vc_btn title=”SEE THE CELEBRATION” align=”center” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Folv.duke.edu%2Finvented-at-duke%2F|||”][\/vc_column][\/vc_row][vc_row equal_height=”yes” el_class=”sections” css=”.vc_custom_1690983788240{margin-bottom: 50px !important;}”][vc_column width=”1\/2″ el_class=”simple-content-box green-box” css=”.vc_custom_1537299972662{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_row_inner el_class=”simple-content-box” css=”.vc_custom_1535540084326{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-color: #a1b70d !important;}”][vc_column_inner][vc_single_image image=”64″ el_class=”right-center”][vc_column_text el_id=”heading3″]<\/p>\n

114<\/h2>\n

AGREEMENTS<\/h4>\n

[\/vc_column_text][vc_btn title=”See More Numbers” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2Fby-the-numbers%2F|title:By%20the%20Numbers||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″ css=”.vc_custom_1537299948245{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 25px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”teal-box-transparent”][vc_row_inner el_class=”content-overlay-box sky-blue-overlay” css=”.vc_custom_1536328657994{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/couple-hikers-success-concept-in-mountains-P7CSEP9.jpg?id=318) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_inner][vc_single_image image=”45″ el_class=”left-center”][vc_column_text]<\/p>\n

NEW START-UP:
\nPrepped Health<\/h2>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp”]<\/p>\n

Offering multiple tools for empowering patients to take control of their healthcare journey<\/p>\n

[\/vc_column_text][vc_btn title=”Read More About Prepped Health” align=”center” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F08%2F27%2Fprepped-health%2F|title:Prepped%20Health||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row equal_height=”yes” el_class=”sections column-3″ css=”.vc_custom_1690983798179{margin-bottom: 50px !important;}”][vc_column width=”1\/3″ css=”.vc_custom_1537299962543{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”teal-box-transparent”][vc_row_inner css=”.vc_custom_1536328543379{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/business-concepts-two-men-are-consulting-a-PK3YZUA.jpg?id=326) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”content-overlay-box sky-blue-overlay small-text”][vc_column_inner][vc_single_image image=”45″ el_class=”left-center”][vc_column_text]<\/p>\n

NEW START-UP:
\nInfinia ML<\/h2>\n

[\/vc_column_text][vc_column_text css_animation=”fadeInUp”]<\/p>\n

Using advanced machine
\nlearning techniques to solve business challenges[\/vc_column_text][vc_btn title=”Read More About Infinia ML” align=”center” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F08%2F27%2Finfinia-ml%2F|title:Infinia%20ML||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1535541212485{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 25px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_row_inner el_class=”content-overlay-box blue-overlay small-text” css=”.vc_custom_1536334086521{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/08\/scientist-working-with-chemicals-in-laboratory-PMJYPJ4.jpg?id=482) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column_inner][vc_single_image image=”118″ el_class=”top-center”][vc_column_text]<\/p>\n

Clinical Trials for Pompe Disease Gene Therapy Begins This Fall<\/h2>\n

[\/vc_column_text][vc_btn title=”Read More” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2F2018%2F08%2F27%2Fpompe-gene-therapy-advances-to-clinical-trials%2F|title:Clinical%20Trials%20for%20Pompe%20Disease%20Gene%20Therapy%20Begins%20This%20Fall||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/3″ css=”.vc_custom_1537299954630{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 25px !important;}” el_class=”green-box”][vc_row_inner el_class=”simple-content-box” css=”.vc_custom_1535541365699{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-color: #a1b70d !important;}”][vc_column_inner][vc_single_image image=”64″ el_class=”right-center”][vc_column_text el_class=”heading4″]<\/p>\n

$<\/sup>51M<\/h2>\n

IN REVENUE<\/h4>\n

[\/vc_column_text][vc_btn title=”See More Numbers” css_animation=”fadeInUp” el_class=”read-more” link=”url:https%3A%2F%2Fnumbers.otc.duke.edu%2F2018-report%2Fby-the-numbers%2F|title:By%20the%20Numbers||”][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row css=”.vc_custom_1535522109481{background-color: #383838 !important;}” el_class=”main-heading”][vc_column css=”.vc_custom_1535525509169{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_column_text] 2018 ANNUAL REPORT [\/vc_column_text][\/vc_column][\/vc_row][vc_row equal_height=”yes” el_class=”sections” css=”.vc_custom_1690983430632{margin-bottom: 50px !important;}”][vc_column width=”2\/3″ css=”.vc_custom_1535531141367{padding-top: 0px !important;padding-right: 25px !important;padding-bottom: 0px !important;padding-left: 0px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_row_inner el_class=”content-overlay-box blue-overlay” css=”.vc_custom_1536327338618{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;background-image: url(https:\/\/numbers.otc.duke.edu\/wp-content\/uploads\/2018\/09\/scientist-working-PDUEQ7K.jpg?id=607) !important;background-position: center !important;background-repeat: no-repeat […]<\/p>\n","protected":false},"author":26,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_exactmetrics_skip_tracking":false,"footnotes":""},"class_list":["post-170","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/pages\/170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/comments?post=170"}],"version-history":[{"count":106,"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/pages\/170\/revisions"}],"predecessor-version":[{"id":848,"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/pages\/170\/revisions\/848"}],"wp:attachment":[{"href":"https:\/\/numbers.otc.duke.edu\/2018-report\/wp-json\/wp\/v2\/media?parent=170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}